Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment InformationMOON SHOTS PROGRAM
Every year in the U.S., approximately 235,000 men and women are diagnosed with breast cancer and more than 40,000 succumb to it. Nearly 69,000 patients have the subtype known as triple-negative breast cancer (TNBC), which causes almost 12,000 deaths annually. The Breast Cancer Moon Shot® is determined to defeat this deadly type of breast cancer.
A flood of new knowledge and technology makes now the time to fast-track the cancer fight and make a giant leap for patients. We're merging today’s high potential for achievement with our unique knowledge and expertise, derived from decades of leadership in the cancer field.
Junjie Chen, Ph.D.
Chair, Experimental Radiation Oncology
Clinton Yam, M.D.
Assistant Professor, Breast Medical Oncology
Gaiane Maia Rauch, M.D., Ph.D.
Professor, Abdominal Imaging
Join our effort to defeat triple-negative breast cancer.
MD Anderson researchers discovered that triple negative breast cancer cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.
Does immunotherapy treat breast cancer?
Breast Cancer Moon Shot co-leader Clinton Yam, M.D., discusses FDA-approved immunotherapy options for metastatic triple-negative breast cancer, which breast cancer patients stand to benefit from immunotherapy and what’s ahead in the field of breast cancer immunotherapy research.
